CINECA IRIS Institutional Research Information System

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Pignata S;Scambia G;Katsaros D;Gallo C;Pujade Lauraine E;De Placido S;Bologna A;Weber B;Raspagliesi F;Panici PB;Cormio G;Sorio R;Cavazzini MG;Ferrandina G;Breda E;Murgia V;Sacco C;Cinieri S;Salutari V;Ricci C;Pisano C;Greggi S;Lauria R;Lorusso D;Marchetti C;Selvaggi L;Signoriello S;Piccirillo MC;DI MAIO, Massimo;Perrone F;Multicentre Italian Trials in Ovarian cancer;Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein;Mario Negri Gynecologic Oncology;European Network of Gynaecological Oncological Trial Groups;Gynecologic Cancer InterGroup Investigators

2014-01-01